Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies

International Journal of Biological Markers

Volumn 25, Issue 4, 2010, Pages 185-194

  Fuhrman, Barbara J ^a   Xu, Xia ^b   Falk, Roni T ^a   Hankinson, Susan E ^c   Veenstra, Timothy D ^b   Keefer, Larry K ^d   Ziegler, Regina G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Estradiol; Estrogen metabolites; Estrogens; Stability; Urine

Indexed keywords

ASCORBIC ACID; ESTROGEN; ESTROGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; FEMALE; FREEZE THAWING; HUMAN; LIQUID CHROMATOGRAPHY; PREMENOPAUSE; PROCESSING; STORAGE; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; THERMOSTABILITY; URINALYSIS;

ASCORBIC ACID; EPIDEMIOLOGIC METHODS; ESTRENES; ESTROGENS; FEMALE; HUMANS; PREMENOPAUSE; PRESERVATION, BIOLOGICAL; TEMPERATURE; TIME FACTORS;

EID: 78650818486     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2010.6086     Document Type: Article

References (22)

1. Eliassen A, Hankinson S. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol 2008; 630: 148-65.
2. Cavalieri E, Chakravarti D, Guttenplan J, et al. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 2006; 1766: 63-78. (Pubitemid 44175632)
3. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000; 67-73.
4. Bradlow HL, Hershcopf R, Martucci C, Fishman J. 16 alpha-Hydroxylation of estradiol: a possible risk marker for breast cancer. Ann N Y Acad Sci 1986; 464: 138-51. (Pubitemid 17197628)
5. Jefcoate CR, Liehr JG, Santen RJ, et al. Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens. J Natl Cancer Inst Monogr 2000; 2000: 95-112.
6. Sasano H, Suzuki T, Miki Y, Moriya T. Intracrinology of estrogens and androgens in breast carcinoma. J Steroid Biochem Mol Biol 2008; 108: 181-5.
7. Zhu B, Han G, Shim J, Wen Y, Jiang X. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 2006; 147: 4132-50.
8. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents: DNA adducts and mutations. J Natl Cancer Inst Monogr 2000; 75-93.
9. Falk RT, Xu X, Keefer L, Veenstra TD, Ziegler RG. A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 2008; 17: 3411-8.
10. Xu X, Veenstra TD, Fox SD, et al. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 2005; 77: 6646-54.
11. MacMahon B, Cole P, Brown JB, et al. Oestrogen profiles of Asian and North American women. Lancet 1971; 2: 900-2.
12. Adlercreutz H, Fotsis T, Bannwart C, et al. Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. J Steroid Biochem 1986; 24: 289-96.
13. Key TJ, Wang DY, Brown JB, et al. A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 1996; 73: 1615-9.
14. Bradlow HL, Sepkovic DW, Klug T, Osborne MP. Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids 1998; 63: 406-13. (Pubitemid 28292784)
15. Tworoger SH, Hankinson SE. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol Biomarkers Prev 2006; 15: 1578-81.
16. Fotsis T, Jarvenpaa P, Adlercreutz H. Purification of urine for quantification of the complete estrogen profile. J Steroid Biochem 1980; 12: 503-8. (Pubitemid 10075379)
17. Fisher A, Naughton D. Iron supplements: the quick fix with long-term consequences. Nutr J 2004; 3: 2.
18. Kesner JS, Knecht EA, Krieg EF Jr. Stability of urinary female reproductive hormones stored under various conditions. Reprod Toxicol 1995; 9: 239-44.
19. O'Connor KA, Brindle E, Holman DJ, et al. Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem 2003; 49: 1139-48.
20. Ye X, Bishop AM, Reidy JA, Needham LL, Calafat AM. Temporal stability of the conjugated species of bisphenol A, parabens, and other environmental phenols in human urine. J Expo Sci Environ Epidemiol 2007; 17: 567-72.
21. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 1819-27.
22. Michaud DS, Manson JE, Spiegelman D, et al. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 1999; 8: 1059-64.